PALB2/FANCN: Recombining cancer and fanconi anemia

Marc Tischkowitz, Bing Xia

Research output: Contribution to journalReview articlepeer-review

167 Scopus citations

Abstract

Partner and localizer of BRCA2 (PALB2) was originally identified as a BRCA2-interacting protein that is crucial for key BRCA2 genome caretaker functions. It subsequently became clear that PALB2 was another Fanconi anemia (FA) gene (FANCN), and that monoallelic PALB2 mutations are associated with increased risk of breast and pancreatic cancer. Mutations in PALB2 have been identified in breast cancer families worldwide, and recent studies have shown that PALB2 also interacts with BRCA1. Here, we summarize the molecular functions and clinical phenotypes of this key DNA repair pathway component and discuss how its discovery has advanced our knowledge of both FA and adult cancer predisposition.

Original languageEnglish (US)
Pages (from-to)7353-7359
Number of pages7
JournalCancer Research
Volume70
Issue number19
DOIs
StatePublished - Oct 1 2010

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'PALB2/FANCN: Recombining cancer and fanconi anemia'. Together they form a unique fingerprint.

Cite this